Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) dropped 2.1% during trading on Thursday . The stock traded as low as $2.30 and last traded at $2.30. Approximately 1,500 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 3,400 shares. The stock had previously closed at $2.35.
Mayne Pharma Group Trading Down 2.1%
The firm’s 50-day simple moving average is $2.20 and its two-hundred day simple moving average is $1.87.
Mayne Pharma Group Company Profile
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
